News

Filter by:

Limit to items where the date of the news item:
Date range
Limit to items where the date of the news item:
Limit to news where the title matches:
Limit to news items tagged with one or more of:
Select All
Limit to news items where the audience is one or more of:
Select All

The spring 2021 term competition circuit was a little quieter than usual, but that did not stop our undergraduate, graduate, alumni students from taking centre stage. Here is a summary of their noteworthy accomplishments during the recent competition season.

It takes a particular kind of resilience to pitch an idea for a startup to a radiologist—while you’re in hospital waiting for your cancer treatment.

That’s exactly what Rachel Bartholomew (MBET ’14) did. Today she is the founder of Hyivy Health, a startup that is developing a rehabilitation system – a connected vaginal wand, a patient app and a portal for clinicians – to help women recover from everything from cervical cancer and gender-affirming surgery to childbirth.

The winter 2021 term was full of competition news for our undergraduate, graduate, alumni students — and their ventures. Here is a summary of their noteworthy accomplishments during the recent competition season.

NERv Technology, a Kitchener-Waterloo-based startup offering a sensory platform designed for the healthtech sector, has closed a $3.32 million CAD ($2.65 million USD) seed round of funding.

The seed round was led by returning investor SOSV, with participation from Graphene Ventures, OneValley, Northspring Capital Partners, Boutique Venture Partners, and Threshold Impact. A number of additional undisclosed strategic investors, angels, and physicians also invested in the round.

Every year, more than 4.5 million people need blood transfusions in Canada and the United States. That amounts to about 36,000 RBC units per day for the US alone. Transfusions are needed for trauma response, surgery and cancer care. The medical system relies on a complex system of blood donations to meet that need. Without a sufficient, reliable supply of safe blood, the health-care system comes into jeopardy.